BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8947306)

  • 1. Periodic naltrexone and propensity to take alcoholic beverage.
    Reid LD; Gardell LR; Chattopadhyay S; Hubbell CL
    Alcohol Clin Exp Res; 1996 Nov; 20(8):1329-34. PubMed ID: 8947306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.
    Gardell LR; Whalen CA; Chattophadyay S; Cavallaro CA; Hubbell CL; Reid LD
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1435-9. PubMed ID: 9394115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage.
    Gardell LR; Hubbell CL; Reid LD
    Alcohol Clin Exp Res; 1996 May; 20(3):584-8. PubMed ID: 8727259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone blocks acquisition of voluntary ethanol intake in rats.
    Davidson D; Amit Z
    Alcohol Clin Exp Res; 1997 Jun; 21(4):677-83. PubMed ID: 9194924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage.
    Gardell LR; Reid LD; Boedeker KL; Liakos TM; Hubbell CL
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1592-8. PubMed ID: 9438517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol.
    Cramer CM; Gardell LR; Boedeker KL; Harris JR; Hubbell CL; Reid LD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):345-56. PubMed ID: 9632216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research with rats germane to medication for alcoholism: consequences of noncompliance.
    Reid ML; Hubbell CL; Douglass AV; Boedeker KL; Reid LD
    Alcohol; 2001 Jul; 24(3):169-77. PubMed ID: 11557302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethanol drinking and naltrexone on subsequent drinking in rats.
    Davidson D; Amit Z
    Alcohol; 1997; 14(6):581-4. PubMed ID: 9401674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection.
    Williams KL; Broadbridge CL
    Alcohol; 2009 Mar; 43(2):119-26. PubMed ID: 19251113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol consumption is enhanced after naltrexone treatment.
    Juárez J; Eliana Bde T
    Alcohol Clin Exp Res; 2007 Feb; 31(2):260-4. PubMed ID: 17250617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor.
    Williams KL; Woods JH
    Alcohol Clin Exp Res; 1998 Nov; 22(8):1634-9. PubMed ID: 9835275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone treatment increases the aversiveness of alcohol for outbred rats.
    Hill KG; Kiefer SW
    Alcohol Clin Exp Res; 1997 Jun; 21(4):637-41. PubMed ID: 9194917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.
    Cowen MS; Rezvani AH; Jarrott B; Lawrence AJ
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1008-14. PubMed ID: 10397284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence.
    Matzeu A; Terenius L; Martin-Fardon R
    Alcohol Clin Exp Res; 2018 Dec; 42(12):2466-2478. PubMed ID: 30320880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats.
    Parkes H; Sinclair JD
    Alcohol; 2000 Jul; 21(3):215-21. PubMed ID: 11091024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding.
    Williams KL
    Alcohol Clin Exp Res; 2007 Jan; 31(1):39-47. PubMed ID: 17207100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study.
    Caputo F; Addolorato G; Lorenzini F; Domenicali M; Greco G; del RE A; Gasbarrini G; Stefanini GF; Bernardi M
    Drug Alcohol Depend; 2003 May; 70(1):85-91. PubMed ID: 12681528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.
    Phillips TJ; Wenger CD; Dorow JD
    Alcohol Clin Exp Res; 1997 Jun; 21(4):691-702. PubMed ID: 9194926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies of opioids and intake of sweetened alcoholic beverage.
    Hubbell CL; Abelson ML; Wild KD; Neuman R; Reid LD
    Alcohol; 1988; 5(2):141-6. PubMed ID: 2840095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.